Skip to main content

Unable to load price data. Sorry.


Keryx Biopharmaceuticals (NASDAQ:KERX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:KERX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

carterhiggins (< 20)
Submitted April 04, 2017

This company has a drug that will help patients before they get to complete renal failure. The drug is currently only in use by dialysis patients, once they get general approval for patients that are starting renal failure - the number of possible… More

TerryHogan (< 20)
Submitted October 03, 2018

Just judging by the financials summaries here on the fool, I'd guess this thing is run by either scientists or lawyers. Better off having a numbers person, or maybe an operations person at the helm. Even a people person can work depending on the… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about KERX.DL.

No one has written a Pitch for KERX.DL stock yet. Tell us why you think KERX.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in KERX.DL.

No players have picked KERX.DL yet. Tell us why you think KERX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for KERX.DL.